Chemoinformaics analysis of Kaempferol-7-O-Alpha-L-Rhamnoside
| Molecular Weight | 432.381 | nRot | 3 |
| Heavy Atom Molecular Weight | 412.221 | nRig | 24 |
| Exact Molecular Weight | 432.106 | nRing | 4 |
| Solubility: LogS | -4.038 | nHRing | 2 |
| Solubility: LogP | 1.438 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 51 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 31 | No. of Aromatic Carbocycles | 2 |
| nHetero | 10 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 21 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 10 | No. of Arom Bond | 17 |
| nHA | 10 | APOL | 56.4259 |
| nHD | 6 | BPOL | 26.1401 |
| QED | 0.348 |
| Synth | 3.893 |
| Natural Product Likeliness | 2.041 |
| NR-PPAR-gamma | 0.967 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.003 |
| Pgp-sub | 0.531 |
| HIA | 0.351 |
| CACO-2 | -6.043 |
| MDCK | 0.00000912 |
| BBB | 0.01 |
| PPB | 0.923527 |
| VDSS | 0.853 |
| FU | 0.0654428 |
| CYP1A2-inh | 0.099 |
| CYP1A2-sub | 0.06 |
| CYP2c19-inh | 0.022 |
| CYP2c19-sub | 0.056 |
| CYP2c9-inh | 0.047 |
| CYP2c9-sub | 0.55 |
| CYP2d6-inh | 0.149 |
| CYP2d6-sub | 0.194 |
| CYP3a4-inh | 0.06 |
| CYP3a4-sub | 0.029 |
| CL | 2.882 |
| T12 | 0.556 |
| hERG | 0.013 |
| Ames | 0.799 |
| ROA | 0.076 |
| SkinSen | 0.067 |
| Carcinogencity | 0.675 |
| EI | 0.022 |
| Respiratory | 0.05 |
| NR-Aromatase | 0.952 |
| Antiviral | Yes |
| Prediction | 0.945589 |